Potentiation of immune checkpoint blockade cancer immunotherapy with oncolytic virus.

Clinical use of dendritic cells for cancer therapy

Localized oncolytic virotherapy overcomes systemic tumor resistance to immune checkpoint blockade immunotherapy

Clinical Implications of Co-Inhibitory Molecule Expression in the Tumor Microenvironment for DC Vaccination: A Game of Stop and Go

Blockade of PD-1/PD-L1 immune checkpoint during DC vaccination induces potent protective immunity against breast cancer in hu-SCID mice

The blockade of immune checkpoints in cancer immunotherapy

PD-1 blockade by CT-011, anti-PD-1 antibody, enhances ex vivo T-cell responses to autologous dendritic cell/myeloma fusion vaccine

Dendritic cell vaccination combined with CTLA4 blockade in patients with metastatic melanoma